Determination of the specific activity of CDK1 and CDK2 as a novel prognostic indicator for early breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO

Volumn 19, Issue 1, 2008, Pages 68-72

  Kim, S J ^a   Nakayama, S ^a   Miyoshi, Y ^a   Taguchi, T ^a   Tamaki, Y ^a   Matsushima, T ^a   Torikoshi, Y ^a   Tanaka, S ^a   Yoshida, T ^a   Ishihara, H ^a   Noguchi, S ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CDK2 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; ESTROGEN; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST TUMOR; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; ENZYMOLOGY; EVALUATION; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MASTECTOMY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NEOPLASM; PAGET NIPPLE DISEASE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CDC2 PROTEIN KINASE; COMBINED MODALITY THERAPY; CYCLIN-DEPENDENT KINASE 2; DISEASE-FREE SURVIVAL; ESTROGENS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 39049086308     PISSN: None     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm358     Document Type: Article

References (0)